title: The CARI guidelines. Inhibition of the renin-angiotensin system.
authors.forename: Peter
authors.initials: P
authors.lastname: Mount
authors.forename: Subramanian Karthik
authors.initials: SK
authors.lastname: Kumar
authors.forename: Robert
authors.initials: R
authors.lastname: MacGinley
authors.forename: Murty
authors.initials: M
authors.lastname: Mantha
authors.forename: Matthew
authors.initials: M
authors.lastname: Roberts
authors.forename: George
authors.initials: G
authors.lastname: Mangos
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007511:Ischemia / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D012078:Renal Artery Obstruction / Q000150:complications / Q000503:physiopathology*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors